SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Enamelon (ENML) - Does anyone follow this? -- Ignore unavailable to you. Want to Upgrade?

To: Greg B. who wrote (422)2/16/1998 1:43:00 PM
From: matthew lamberson  Read Replies (1) | Respond to of 863
 
Very interesting...things keep unraveling! I am interested in the outcome of the clinical trials as well.



To: Greg B. who wrote (422)2/20/1998 11:23:00 PM
From: RFH  Read Replies (2) | Respond to of 863
 
I spent some time at the Enamelon booth at the Mid Winter Meeting in Chicago yesterday and today, and specifically asked if Enamelon was beneficial for tooth sensitivity. I was told that it was not intended for this purpose, and that they are working on a "sensitivity" formulation for release sometime in the future.

I'll give more info on their presentation, as well as Colgate's comments, to any who are interested.

RFH


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News